![]() |
Volumn 66, Issue 3, 1990, Pages 279-284
|
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®1 1 Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan.
a,b,c,d,e,f,g,h,i,j,k,l
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOSOL;
ADULT;
AGED;
ARTICLE;
CONTROLLED STUDY;
FEMALE;
HEART MUSCLE ISCHEMIA;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
AGED;
ANGINA PECTORIS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
BLOOD SUBSTITUTES;
COMBINED MODALITY THERAPY;
CORONARY CIRCULATION;
CORONARY DISEASE;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAPHY;
FEMALE;
FLUOROCARBONS;
HUMAN;
MALE;
MIDDLE AGE;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0025284138
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/0002-9149(90)90836-P Document Type: Article |
Times cited : (69)
|
References (16)
|